Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

tag hemlibra

Can gene therapies for haemophilia defend their high price tags?

Pharmaceutical Technology

NOVEMBER 9, 2022

million price tag. Both factor VIII prophylactics and Roche’s bispecific antibody Hemlibra that are used for haemophilia A patients are expensive, and so a gene therapy could save money, says Dr. David Rind, chief medical officer (CMO) of ICER. But the case becomes more complicated when it comes to comparisons with Hemlibra.

Gene Therapy

Gene Therapy Gene FDA Approval Medicine

Roctavian okay sets up another gene therapy test for Europe

pharmaphorum

AUGUST 26, 2022

BioMarin will no doubt have an eye on the earlier experience of bluebird bio, which secured EU approval for rare disease gene therapy Zynteglo (betibeglogene autotemcel) in 2019 for beta thalassaemia with a price tag of around €1.6 million spread over five years.

Gene Therapy

Gene Therapy Gene Antibody Marketing

Can gene therapies for haemophilia defend their high price tags?

Roctavian okay sets up another gene therapy test for Europe

Stay Connected